Business
Positive guidance from the US FDA on Cu-64 SARTATE Phase III
Positive guidance from the US FDA on Cu-64 SARTATE Phase III
About this update from Clarity Pharmaceuticals Ltd.
[{"type":"text","content":"Clarity Pharmaceuticals Ltd has released a press release. View Attachment","length":251,"tagName":"div"}]